[go: up one dir, main page]
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2015 3
2016 7
2017 7
2018 6
2019 6
2020 8
2021 4
2022 2
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dan eik hoefsten (1 results)?
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators. Engstrøm T, et al. Among authors: hofsten de. Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1. Lancet. 2015. PMID: 26347918 Clinical Trial.
To defer, or not to defer, that is the question.
Kelbæk H, Høfsten DE, Engstrøm T. Kelbæk H, et al. Among authors: hofsten de. EuroIntervention. 2017 Jul 20;13(4):381-382. doi: 10.4244/EIJV13I4A58. EuroIntervention. 2017. PMID: 28735249 Free article. No abstract available.
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
Campo G, Böhm F, Engstrøm T, Smits PC, Elgendy IY, McCann GP, Wood DA, Serenelli M, James S, Høfsten DE, Boxm-de Klerk BM, Banning A, Cairns JA, Pavasini R, Stankovic G, Kala P, Kelbæk H, Barbato E, Srdanovic I, Hamza M, Banning AS, Biscaglia S, Mehta S. Campo G, et al. Among authors: hofsten de. Circulation. 2024 Nov 5;150(19):1508-1516. doi: 10.1161/CIRCULATIONAHA.124.071493. Epub 2024 Sep 1. Circulation. 2024. PMID: 39217603
Thoracentesis to alleviate pleural effusion in acute heart failure: study protocol for the multicentre, open-label, randomised controlled TAP-IT trial.
Glargaard S, Thomsen JH, Løgstrup BB, Schou M, Iversen KK, Tuxen C, Nielsen OW, Bang CA, Lindholm MG, Seven E, Barasa A, Stride N, Vraa S, Tofterup M, Rasmussen RV, Høfsten DE, Rossing K, Køber L, Gustafsson F, Thune JJ. Glargaard S, et al. Among authors: hofsten de. BMJ Open. 2024 Jan 19;14(1):e078155. doi: 10.1136/bmjopen-2023-078155. BMJ Open. 2024. PMID: 38245015 Free PMC article.
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, Marcaggi X, Tardif JC, McGillion M, Tanguay JF, Brophy J, Yu CW, Berry C, Carrick D, Høfsten DE, Engstrøm T, Kober L, Kelbæk H, Belle L. Jolicoeur EM, et al. Among authors: hofsten de. Can J Cardiol. 2020 Nov;36(11):1805-1814. doi: 10.1016/j.cjca.2020.01.019. Epub 2020 Jan 25. Can J Cardiol. 2020. PMID: 32798463 Review.
Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH.
Doi SN, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Rørth R, Kristensen SL, Bruun NE, Gustafsson F, Eiskjær H, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Butt JH. Doi SN, et al. Among authors: hofsten de. Circ Heart Fail. 2023 Oct;16(10):e010606. doi: 10.1161/CIRCHEARTFAILURE.123.010606. Epub 2023 Sep 27. Circ Heart Fail. 2023. PMID: 37753706 No abstract available.
Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: Comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c.
Pararajasingam G, Høfsten DE, Løgstrup BB, Egstrup M, Henriksen FL, Hangaard J, Egstrup K. Pararajasingam G, et al. Among authors: hofsten de. Int J Cardiol. 2016 Jul 1;214:310-5. doi: 10.1016/j.ijcard.2016.03.199. Epub 2016 Mar 31. Int J Cardiol. 2016. PMID: 27085117 Review.
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
Bravo CA, Hirji SA, Bhatt DL, Kataria R, Faxon DP, Ohman EM, Anderson KL, Sidi AI, Sketch MH Jr, Zarich SW, Osho AA, Gluud C, Kelbæk H, Engstrøm T, Høfsten DE, Brennan JM. Bravo CA, et al. Among authors: hofsten de. Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2. Cochrane Database Syst Rev. 2017. PMID: 28470696 Free PMC article. Review.
47 results